What Happened?
Shares of health care services provider Encompass Health (NYSE: EHC) jumped 7% in the morning session after the company reported strong first-quarter 2026 financial results that beat Wall Street expectations and raised its full-year earnings guidance.
For the quarter, the healthcare provider announced a 9.0% year-on-year increase in net operating revenue to $1.59 billion, surpassing analyst estimates. Adjusted earnings per share grew 16.8% to $1.60, which was also ahead of consensus forecasts. The positive results and improved profit forecast appeared to outweigh initial investor concerns that briefly pushed shares lower, driving the stock higher during the session.
Is now the time to buy Encompass Health? Access our full analysis report here, it’s free.
What Is The Market Telling Us
Encompass Health’s shares are not very volatile and have only had 5 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful, although it might not be something that would fundamentally change its perception of the business.
The biggest move we wrote about over the last year was 3 months ago when the stock gained 11.9% on the news that the company reported strong fourth-quarter earnings and raised its profit forecast for the full year 2026.
The healthcare provider announced fourth-quarter adjusted earnings of $1.46 per share, significantly beating the consensus estimate of $1.30. Revenue for the quarter rose 9.9% year on year to $1.54 billion, which met Wall Street's expectations.
However, the key driver for the stock's move appeared to be the company's optimistic outlook. Encompass Health guided for full-year 2026 adjusted earnings per share of $5.96 at the midpoint, which surpassed analyst projections. This positive guidance, coupled with improved operating and free cash flow margins in the quarter, suggested strong underlying business health and boosted investor confidence.
Encompass Health is flat since the beginning of the year, and at $106.89 per share, it is trading 16% below its 52-week high of $127.18 from October 2025. Investors who bought $1,000 worth of Encompass Health’s shares 5 years ago would now be looking at an investment worth $1,266.
ONE MORE THING: The $21 AI Application Stock Wall Street Forgot. While Wall Street obsesses over who’s building AI, one company is already using it to print money. And nobody’s paying attention.
AI chip stocks trade at ridiculous valuations. This company processes a trillion consumer signals monthly using AI and trades at a third of the price. The gap won’t last. The institutions will figure it out. You need to see this first. Read the FREE Report Before They Notice.
